Role of Nicotine in Lung Carcinogenesis
Role of Nicotine in Lung Carcinogenesis
批准号:
7650431
负责人:
CHANGYAN CHEN
金额:
$32.3万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-08-15 至 2012-05-31
关键词:
AffectApoptosisApoptoticBindingBiochemicalBiologicalBlood CirculationBrainCancer EtiologyCancer PatientCarcinogensCell Cycle CheckpointCell Cycle ProgressionCell ProliferationCholinergic ReceptorsCigaretteCyclin D1DataDevelopmentDrosophila acetylcholine receptor alpha-subunitEnhancersEnvironmentEnvironmental Tobacco SmokeEpithelialEpithelial CellsEventExposure toG CellsGrowthHumanLungMalignant NeoplasmsMalignant neoplasm of lungMediatingMitogensMolecularMolecular TargetMusNeurogliaNicotineNicotine DependencePathway interactionsPatientsPhosphorylationPhosphotransferasesPlayProtein Kinase CRadiation therapyRas Signaling PathwayRattusResearch PersonnelResistanceRoleSignal PathwaySignal TransductionSmokerSurfaceSynaptic TransmissionTestingTherapeutic UsesTobaccoTobacco useUp-RegulationVascular Endothelial Cellbasecancer cellcell growthcell typechronic paincigarette smokingcigarette smokingcyclin Gin vivoinsightlung cancer preventionlung carcinogenesislung tumorigenesisnoveloverexpressionprogramsras Proteinsreceptorresearch studyresponsesmoking cessationtumorigenesis
中文摘要
描述(由申请人提供):吸烟与肺癌的发病密切相关,统计学上超过90%的肺癌患者是吸烟者。 然而,二手烟导致的肺癌仍然未知。尼古丁是香烟的主要成分,在吸烟者的血液中浓度很高。尼古丁产品被广泛用于帮助戒烟和治疗临床慢性疼痛患者。研究表明,尼古丁与尼古丁乙酰胆碱受体(nAChR)结合,并进一步激活各种类型细胞(包括肺上皮细胞和癌细胞以及血管内皮细胞)中的几种促分裂原相关信号通路。Bcl-2的抗凋亡活性也被尼古丁处理诱导。我们证明,尼古丁激活Ras和蛋白激酶C(PKC)途径,导致细胞生长限制的破坏。然而,尼古丁在肺癌发生或发展中的机制仍有待阐明。因此,我们建议的长远目标是研究尼古丁在肺癌发生中的作用。这项研究将确定尼古丁介导的信号通路中的新成分,并有助于改变目前尼古丁的使用。该提案的中心假设是尼古丁作为一种潜在的致癌物,可以动员细胞内生长相关的信号通路并拮抗凋亡信号,从而为肿瘤发生创造一个允许的环境。验证这一假设的具体目的是:1)研究尼古丁介导的细胞生长促进机制; 2)确定尼古丁暴露如何干扰G1期细胞周期检查点; 3)研究尼古丁介导的抗凋亡作用的分子机制。小鼠或大鼠肺上皮细胞和各种人肺癌细胞将用于所提出的实验中。我们对尼古丁的了解不仅将为这种化合物的治疗用途提供警示,而且还有助于开发治疗尼古丁成瘾或慢性疼痛停止的新策略。
英文摘要
DESCRIPTION (provided by applicant): Cigarette smoking is strongly correlated with onset of lung cancer and statistically more than 90% of lung cancer patients are smokers. However, lung cancer caused by second-hand smoking remains unknown. Nicotine is a major component of cigarettes and exists at high concentrations in the bloodstream of smokers. Nicotine-based products are widely used to aid smoking cessation and to treat patients clinically with chronic pain. Studies have shown that nicotine binds to nicotine acetylcholine receptors (nAChRs) and further activates several mitogen-related signaling pathways in various types of cells including lung epithelial and cancer cells and vascular endothelial cells. The anti-apoptotic activity of Bcl-2 is also induced by nicotine treatment. We demonstrated that nicotine activates Ras and protein kinase C (PKC) pathways, leading to the disruption of cell growth restriction. However, the mechanisms of nicotine in the onset or development of lung cancer remain to be elucidated. Therefore, our long-term objective of the proposal is to study the role of nicotine in lung carcinogenesis. Such study will identify novel components in nicotine-mediated signaling pathways and will help modifying the current usage of nicotine. The central hypothesis of the proposal is that nicotine acts as a potential carcinogen that can mobilize intracellular growth-related signal pathways and antagonize apoptotic signaling, which creates a permissive environment for tumorigenesis. The specific aims to test the hypothesis are: 1) to investigate the mechanisms of nicotine-mediated cell growth promotion; 2) to determine how nicotine exposure perturbs G1 cell cycle checkpoint; 3) to study the molecular mechanisms of nicotine-mediated anti-apoptotic action. Mouse or rat lung epithelial and various human lung cancer cells will be used in the proposed experiments. Our understanding of nicotine will not only offer a cautionary stance for the therapeutic use of this compound, but also help developing new stratigies for treating nicotine addiction or chronic pain cessation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Study of Anti-Survival signals in NF1
-
批准号:8450776
-
项目类别:
-
资助金额:$30.33万
-
财政年份:2012
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Anti-Survival signals in NF1
-
批准号:8250719
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2012
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Anti-Survival signals in NF1
-
批准号:9108255
-
项目类别:
-
资助金额:$32.27万
-
财政年份:2012
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Anti-Survival signals in NF1
-
批准号:8701248
-
项目类别:
-
资助金额:$8.75万
-
财政年份:2012
-
负责人:CHANGYAN CHEN
-
依托单位:
Role of Nicotine in Lung Carcinogenesis
-
批准号:8716260
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2007
-
负责人:CHANGYAN CHEN
-
依托单位:
Role of Nicotine in Lung Carcinogenesis
-
批准号:7825419
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2007
-
负责人:CHANGYAN CHEN
-
依托单位:
Role of Nicotine in Lung Carcinogenesis
-
批准号:7175648
-
项目类别:
-
资助金额:$32.3万
-
财政年份:2007
-
负责人:CHANGYAN CHEN
-
依托单位:
Role of Nicotine in Lung Carcinogenesis
-
批准号:7484134
-
项目类别:
-
资助金额:$34.8万
-
财政年份:2007
-
负责人:CHANGYAN CHEN
-
依托单位:
Role of Nicotine in Lung Carcinogenesis
-
批准号:8081040
-
项目类别:
-
资助金额:$27.21万
-
财政年份:2007
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:8852561
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:7240415
-
项目类别:
-
资助金额:$26.44万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:6826031
-
项目类别:
-
资助金额:$25.23万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:6913618
-
项目类别:
-
资助金额:$26.49万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:7489969
-
项目类别:
-
资助金额:$26.44万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:9056560
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:8431132
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:9257294
-
项目类别:
-
资助金额:$24.18万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
Study of Ras-Mediated Apoptosis
-
批准号:7117798
-
项目类别:
-
资助金额:$25.86万
-
财政年份:2004
-
负责人:CHANGYAN CHEN
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: